Atlas Trials

Evaluation of the Safety and Efficacy of Azvudine and Paxlovid in the Treatment of Hospitalized Patients With COVID-19

Clinical trial NCT05996770 · UNKNOWN

Trial details

NCT number
NCT05996770
Sponsor
Xiao Li,MD
Status
UNKNOWN
Study type
OBSERVATIONAL
PaxlovidAzvudineCOVID-19
Start date
2024-06-01
Primary completion
2024-07-31
Enrollment
1500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.